<DOC>
	<DOCNO>NCT02142634</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy budesonide treatment active incomplete microscopic colitis .</brief_summary>
	<brief_title>Budesonide Induction Remission Incomplete Microscopic Colitis</brief_title>
	<detailed_description>N.A .</detailed_description>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Colitis , Microscopic</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Histologically establish diagnosis incomplete microscopic colitis ( MCi ) History chronic nonbloody , watery diarrhoea Clinically active disease Other significant abnormality colonoscopy Infectious cause diarrhoea Clinical suspicion druginduced diarrhoea Prior present MC History bowel resection Radiation therapy abdominal pelvic region Positive antibody titres celiac disease Untreated active thyroid dysfunction Any severe concomitant cardiovascular , renal , endocrine , psychiatric disorder reduce life expectancy Abnormal hepatic function Tuberculosis , hypertension , diabetes mellitus , osteoporosis , peptic ulcer disease , glaucoma , cataract , infection careful medical monitoring ensure History colorectal cancer History cancer ( colorectal ) last 5 year Therapy immunomodulators/budesonide steroids/antibiotics/antidiarrhoeal drug Current intend pregnancy breastfeed Doubt patient 's cooperation , e.g . addiction alcohol drug Participation another clinical trial within last 30 day , simultaneous participation another clinical trial , previous participation trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>